Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “S-1 Plus Oxaliplatin”

100 trials

Showing 20 of 100 results

Large-scale testing (Phase 3)UnknownNCT02817425
What this trial is testing

A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer

Who this might be right for
Gastric Cancer
LanZhou University 300
Testing effectiveness (Phase 2)Study completedNCT03878472
What this trial is testing

Neoadjuvant Immunotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Qilu Hospital of Shandong University 25
Early research (Phase 1)UnknownNCT00506207
What this trial is testing

A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy

Who this might be right for
Colorectal NeoplasmGastric NeoplasmSecondary
National Cancer Center, Korea 23
Large-scale testing (Phase 3)Temporarily pausedNCT00316745
What this trial is testing

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 200
Testing effectiveness (Phase 2)UnknownNCT01542294
What this trial is testing

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 71
Testing effectiveness (Phase 2)UnknownNCT06475417
What this trial is testing

Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Tang-Du Hospital 42
Testing effectiveness (Phase 2)UnknownNCT02623153
What this trial is testing

Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer

Who this might be right for
Gastric Cancer
Tianshu Liu 200
Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06510010
What this trial is testing

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Who this might be right for
Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University 198
Testing effectiveness (Phase 2)Ended earlyNCT02216149
What this trial is testing

Effects of S-1 and Capecitabine on Coronary Artery Blood Flow

Who this might be right for
Esophagus CancerStomach CancerSmall Bowel Cancer+2 more
Heikki Joensuu 20
Early research (Phase 1)Study completedNCT02347904
What this trial is testing

Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Large-scale testing (Phase 3)UnknownNCT03961867
What this trial is testing

Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 440
Testing effectiveness (Phase 2)UnknownNCT04694404
What this trial is testing

Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer

Who this might be right for
S-1 Plus Oxaliplatin
Aiping Zhou 60
Testing effectiveness (Phase 2)Study completedNCT03726021
What this trial is testing

Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

Who this might be right for
Overall Survival
Qingdao Central Hospital 47
Testing effectiveness (Phase 2)UnknownNCT00985556
What this trial is testing

Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer
Yonsei University 130
Testing effectiveness (Phase 2)UnknownNCT00587145
What this trial is testing

Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
National Cancer Center, Korea 44
Large-scale testing (Phase 3)UnknownNCT01761461
What this trial is testing

Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial

Who this might be right for
Gastric Cancer
Samsung Medical Center 547
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07374250
What this trial is testing

Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric CancerRCT
Sichuan University 154
Testing effectiveness (Phase 2)UnknownNCT02024217
What this trial is testing

Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma

Who this might be right for
Gastric Cancer
Fudan University 40
Not applicableEnded earlyNCT03349827
What this trial is testing

HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer

Who this might be right for
Peritoneal Metastases From Gastric Cancer
Wuhan University 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation